BIOVECTRA
An Agilent-owned Canadian CDMO with officially disclosed pDNA, mRNA, and LNP formulation capabilities.
CanadaFull profile →
Find your next research lead.
All cataloged profiles, sources, filters, and comparisons are open. Sign in to save companies, keep private notes, and join discussions.
471 company identities · 13 technology & service fields
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
51 matching companies
Samsung Biologics
Offers mRNA drug substance and drug product services, including process development, analysis, and product characterization. Each site's project scope requires confirmation.
South KoreaFull profile →
AGC Biologics
Offers mRNA process development and cGMP manufacturing based on microbial, DNA, and RNA production and analytical capabilities. Capabilities are not necessarily equivalent across all AGC sites.
Japan / United States / GermanyFull profile →
Coverage expands from sourced records; this database does not claim all biopharma companies.